Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)
Public ClinicalTrials.gov record NCT00864227. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Phase II Trial of Non-Myeloablative Conditioning (NST) and Transplantation of Umbilical Cord Blood (UCB) From Unrelated Donors in Patients With Hematologic Malignancies (BMT CTN #0604)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A bone marrow transplant, which is a type of stem cell transplant, is a treatment option for people with leukemia or lymphoma. Recently, stem cell transplants using umbilical cord blood have become a treatment option for people with these types of cancers. This study will evaluate the effectiveness of a stem cell transplant using umbilical cord blood, along with lower doses of chemotherapy, to treat people with leukemia or lymphoma.
Study identification
- NCT ID
- NCT00864227
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 54 participants
Conditions and interventions
Conditions
Interventions
- Hematopoietic Umbilical Cord Blood Stem Cell Transplantation Biological
- GVHD prophylaxis Biological
Biological
Eligibility (public fields only)
- Age range
- 1 Year to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2008 (Type not available)
- Primary completion
- Apr 2011 (Actual)
- Completion
- Nov 2013 (Actual)
- Last update posted
- Dec 14, 2022
2008 – 2013
United States locations
- U.S. sites
- 16
- U.S. states
- 14
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope National Medical Center | Duarte | California | 91010 | — |
| University of Florida College of Medicine, Shands | Gainesville | Florida | 32610-3633 | — |
| H. Lee Moffitt Cancer Center | Tampa | Florida | 33624 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242-1009 | — |
| University of Kansas Hospital | Kansas City | Kansas | 66160 | — |
| Dana-Farber Cancer Institute (DFCI), Brigham & Women's Hospital Brigham and Women's Hospital | Boston | Massachusetts | 02114 | — |
| Dana-Farber Cancer Institute (DFCI), Massachusetts General Hospital Dana-Farber Cancer Institute | Boston | Massachusetts | 02114 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Washington University, Barnes Jewish Hospital | St Louis | Missouri | 63110 | — |
| Weill Cornell Medical College, NY Presbyterian Hospital | New York | New York | 10065 | — |
| Ohio State, Arthur G. James Cancer Hospital | Columbus | Ohio | 43210 | — |
| University of Pennsylvania Cancer Center | Philadelphia | Pennsylvania | 19104 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Texas Transplant Institute | San Antonio | Texas | 78229 | — |
| Virginia Commonwealth University, Medical College of Virginia (MCV) Hospital | Richmond | Virginia | 23298 | — |
| University of Wisconsin Hospital and Clinics | Madison | Wisconsin | 53792-5156 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00864227, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 14, 2022 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00864227 live on ClinicalTrials.gov.